Substantial Overpayment. The report to OIG shall include:
a. a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions, or other conduct giving rise to the Reportable Event; the period during which the conduct occurred; and the names of entities and individuals believed to be implicated, including an explanation of their roles in the Reportable Event;
b. the Federal health care programs affected by the Reportable Event;
c. a description of the steps taken by CHN to identify and quantify any Overpayments; and
d. a description of CHN’s actions taken to correct the Reportable Event and prevent it from recurring. Within 60 days of identification of the substantial Overpayment, CHN shall repay the Overpayment, in accordance with the requirements of 42 U.S.C. § 1320a-7k(d) and any applicable regulations and Centers for Medicare and Medicaid Services (CMS) guidance, and provide OIG with documentation of the repayment.
Substantial Overpayment. The report to OIG shall include:
a. a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions, or other conduct giving rise to the Reportable Event; the period during which the conduct occurred; and the names of individuals and entities believed to be implicated, including an explanation of their roles in the Reportable Event;
b. the Federal health care programs affected by the Reportable Event;
c. a description of the steps taken by JSK to identify and quantify the Overpayment; and
d. a description of JSK’s actions taken to correct the Reportable Event and prevent it from recurring. Within 60 days of identification of the substantial Overpayment, JSK shall repay the Overpayment, in accordance with the requirements of 42 U.S.C. § 1320a-7k(d) and any applicable regulations and CMS guidance, and provide OIG with documentation of the repayment.
Substantial Overpayment. The report to OIG shall include:
a. a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions, or other conduct giving rise to the Reportable Event; the period during which the conduct occurred; and the names of entities and individuals believed to be implicated, including an explanation of their roles in the Reportable Event;
b. the Federal health care programs affected by the Reportable Event;
c. a description of the steps taken by Provider to identify and quantify any Overpayments; and
Substantial Overpayment. The report to OIG shall include:
a. a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions, or other conduct giving rise to the Reportable Event; the period during which the conduct occurred; and the names of individuals and entities believed to be implicated, including an explanation of their roles in the Reportable Event;
b. the Federal health care programs affected by the Reportable Event;
c. a description of the steps taken by [Practitioner] to identify and quantify the Overpayment; and
d. a description of [Practitioner]’s actions taken to correct the Reportable Event and prevent it from recurring. Within 60 days of identification of the substantial Overpayment, [Practitioner] shall repay the Overpayment, in accordance with the requirements of 42 U.S.C. § 1320a-7k(d) and any applicable regulations and CMS guidance, and provide OIG with documentation of the repayment.
Substantial Overpayment. The report to OIG shall include:
a. a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions, or other conduct giving rise to the Reportable Event; the period during which the conduct occurred; and the names of individuals and entities believed to be implicated, including an explanation of their roles in the Reportable Event;
b. the Federal health care programs affected by the Reportable Event;
c. a description of the steps taken by BioTek to identify and quantify the Overpayment; and
d. a description of BioTek’s actions taken to correct the Reportable Event and prevent it from recurring. Within 60 days of identification of the substantial Overpayment, BioTek shall repay the Overpayment, in accordance with the requirements of 42 U.S.C. § 1320a-7k(d) and any applicable regulations and Centers for Medicare and Medicaid Services (CMS) guidance, and provide OIG with documentation of the repayment.
Substantial Overpayment. The report to OIG shall include:
a. a complete description of all details relevant to the Reportable Event, including, at a minimum, the types of claims, transactions, or other conduct giving rise to the Reportable Event; the period during which the conduct occurred; and the names of individuals and entities believed to be implicated, including an explanation of their roles in the Reportable Event;
b. the Federal health care programs affected by the Reportable Event;
c. a description of the steps taken by Florida Cardiology to identify and quantify the Overpayment; and
d. a description of Florida Cardiology’s actions taken to correct the Reportable Event and prevent it from recurring. Within 60 days of identification of the substantial Overpayment, Florida Cardiology shall repay the Overpayment, in accordance with the requirements of 42 U.S.C. § 1320a-7k(d) and any applicable regulations and CMS guidance, and provide OIG with documentation of the repayment.
